Point72 Asia (Singapore) Pte. Ltd. Eton Pharmaceuticals, Inc. Transaction History
Point72 Asia (Singapore) Pte. Ltd.
- $379 Billion
- Q4 2024
A detailed history of Point72 Asia (Singapore) Pte. Ltd. transactions in Eton Pharmaceuticals, Inc. stock. As of the latest transaction made, Point72 Asia (Singapore) Pte. Ltd. holds 10,561 shares of ETON stock, worth $164,962. This represents 0.04% of its overall portfolio holdings.
Number of Shares
10,561
Previous 8,927
18.3%
Holding current value
$164,962
Previous $53.6 Million
162.64%
% of portfolio
0.04%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding ETON
# of Institutions
74Shares Held
13.1MCall Options Held
284KPut Options Held
4.2K-
Opaleye Management Inc. Boston, MA2.85MShares$44.5 Million7.38% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA1.83MShares$28.6 Million1.12% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT1.12MShares$17.5 Million0.74% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.06MShares$16.6 Million0.0% of portfolio
-
Westside Investment Management, Inc.575KShares$8.98 Million1.61% of portfolio
About Eton Pharmaceuticals, Inc.
- Ticker ETON
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,297,000
- Market Cap $395M
- Description
- Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for th...